About NEUCYTE INC
NeuCyte, Inc. is a biotech company focused on generating quality iPSC-derived neural cells to develop treatments for neurological disorders. Their proprietary platform is used for CNS disease modeling, target validation, custom cell production, and compound screening.
Generating quality iPSC-derived neural cellsCNS disease modelingTarget validationCustom cell productionCompound screeningElectrophysiology and high content imaging systemsGenomic and biochemical analysisFunctional phenotypic assessment
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| BAA - EXEMPT - LABORATORY SUPPLIES | Environmental Protection Agency | $37K | |
| A MINIATURIZED AD MPS PLATFORM FOR HIGH-THROUGHPUT DRUG SCREENING | Department of Health and Human Services | $500K |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to NEUCYTE INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.